Skip to content
Breaking
Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment
Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests
Bradyzoite subtypes rule the crossroads of Toxoplasma development
Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund
Welcoming Three New Leaders to the CureSearch Board of Directors
A Pan-Canadian Team Develops Revolutionary Egg-Based Tumor Model for Rapid, Personalized Cancer Treatment Discovery
Estrogen Hormone Regulates Female Binge Drinking, Driving Rapid Alcohol Consumption and Contributing to Sex Differences in Behavior
Routine Calcium and Vitamin D Supplementation Offers Little Benefit Against Falls and Fractures for Most Older Adults, Major Review Concludes
The Dual Nature of a Crucial Enzyme: PI3K Possesses Both Accelerator and Brake for Cell Migration
Genetically Tailored Treatment Plans for Children with Wilms Tumour Promise More Effective Care and Minimized Side Effects
21 Sep 2026, Mon
Cancerilles

Cancerilles

Knowledge and News for the Global Fight Against Cancer.

  • Home
  • About Us
    • About Us
    • Advertising Policy
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • DMCA
    • Privacy Policy
    • Terms of Service
  • Contact Us
  • FAQ
  • Sitemap
Biotech, Pharma & Cancer Drug Development

Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment

admin Sep 21, 2026
Hematology, Leukemia & Lymphoma

Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests

Hendra Lukman Sep 21, 2026
Biotech, Pharma & Cancer Drug Development

Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment

admin Sep 21, 2026
Hematology, Leukemia & Lymphoma

Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests

Hendra Lukman Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)

Bradyzoite subtypes rule the crossroads of Toxoplasma development

George Ongkojoyo Sep 21, 2026
Pediatric Oncology & Childhood Cancers

Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund

admin Sep 21, 2026
Uncategorized

Welcoming Three New Leaders to the CureSearch Board of Directors

admin Sep 21, 2026
Biotech, Pharma & Cancer Drug Development

Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment

Sep 21, 2026
Hematology, Leukemia & Lymphoma

Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests

Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)

Bradyzoite subtypes rule the crossroads of Toxoplasma development

Sep 21, 2026
Pediatric Oncology & Childhood Cancers

Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund

Sep 21, 2026
Pediatric Oncology & Childhood Cancers

From Tech Innovation to Philanthropic Impact How Alex Monahan is Leveraging Resources to Transform Childhood Cancer Research

admin Sep 14, 2026

The transition from a high-growth technology startup to the world of high-impact philanthropy is a...

Uncategorized

CureSearch Young Investigator Award Recipient Dr. Kathryn Taylor Advances Revolutionary Research into Aggressive Pediatric Brain Tumors

admin Sep 14, 2026

The landscape of pediatric oncology is undergoing a paradigm shift as researchers move beyond traditional...

Immunotherapy & CAR-T Research

The Silent Epidemic: Understanding and Addressing Lung Cancer in Never-Smokers

admin Sep 14, 2026

For decades, lung cancer has been inextricably linked with tobacco smoking, a connection deeply rooted...

Neuro-Oncology (Brain & CNS)

Unprecedented Spinal Cord Injury Recovery Rates Achieved Through Vagus Nerve Stimulation and Personalized Rehabilitation

Nana O Sep 14, 2026

In a groundbreaking clinical study, researchers from the Texas Biomedical Device Center (TxBDC) at The...

Breast Cancer: Research & Awareness

Revolutionary Research Uncovers Dual Nature of Immune Cells in Colorectal Cancer, Paving the Way for Targeted Immunotherapies

Billy Candra Sep 14, 2026

A groundbreaking study from the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center (MSK)...

Breaking Oncology News & General Research

A Disturbing Trend: Younger Generations Show Signs of Accelerated Biological Aging, Increasing Early-Onset Cancer Risk

Budi Oetomo Narendra Sep 14, 2026

Cancer is a disease historically and strongly associated with age, a grim consequence of the...

Gastrointestinal & Colorectal Cancers

New Study Reveals Advanced Prostate Cancer May Be More Widespread Than Previously Understood, Challenging Traditional Imaging Standards

Gilang Cahya Sep 14, 2026

A groundbreaking study conducted by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has...

Lung Cancer & Thoracic Oncology

Volcanic Ash From Kīlauea Eruption Fueled Massive North Pacific Phytoplankton Bloom, Study Reveals

Lina carolina Sep 14, 2026

The colossal eruption of Kīlauea volcano in May 2018, which sent an immense plume of...

Genitourinary, Prostate & Kidney Cancer

Navigating the Complexities of Dietary Supplementation in the Aging Population: A Data-Driven Analysis of Risks and Benefits

Gabriel Paijo Sep 14, 2026

The global dietary supplement market has witnessed an unprecedented surge, currently valued at over $170...

Hematology, Leukemia & Lymphoma

Vitamin D Supplements Show No Benefit for COVID-19 Severity but May Hold Promise for Long COVID

Hendra Lukman Sep 14, 2026

Findings from a large-scale, rigorous randomized controlled trial led by Mass General Brigham suggest that...

Posts pagination

1 … 32 33 34 … 365

Posts Carousel

Biotech, Pharma & Cancer Drug Development

Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment

admin Sep 21, 2026
Hematology, Leukemia & Lymphoma

Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests

Hendra Lukman Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)

Bradyzoite subtypes rule the crossroads of Toxoplasma development

George Ongkojoyo Sep 21, 2026
Pediatric Oncology & Childhood Cancers

Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund

admin Sep 21, 2026
Uncategorized

Welcoming Three New Leaders to the CureSearch Board of Directors

admin Sep 21, 2026
Trending
Popular
Latest
Biotech, Pharma & Cancer Drug Development
Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment
Sep 21, 2026
Hematology, Leukemia & Lymphoma
Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests
Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)
Bradyzoite subtypes rule the crossroads of Toxoplasma development
Sep 21, 2026
Pediatric Oncology & Childhood Cancers
Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund
Sep 21, 2026
Biotech, Pharma & Cancer Drug Development
Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment
Sep 21, 2026
Hematology, Leukemia & Lymphoma
Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests
Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)
Bradyzoite subtypes rule the crossroads of Toxoplasma development
Sep 21, 2026
Pediatric Oncology & Childhood Cancers
Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund
Sep 21, 2026
Biotech, Pharma & Cancer Drug Development
Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment
Sep 21, 2026
Hematology, Leukemia & Lymphoma
Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests
Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)
Bradyzoite subtypes rule the crossroads of Toxoplasma development
Sep 21, 2026
Pediatric Oncology & Childhood Cancers
Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund
Sep 21, 2026

You Missed

Biotech, Pharma & Cancer Drug Development

Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment

Hematology, Leukemia & Lymphoma

Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests

Gynecologic Oncology (Ovarian, Cervical)

Bradyzoite subtypes rule the crossroads of Toxoplasma development

Pediatric Oncology & Childhood Cancers

Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund

Cancerilles

Cancerilles

Knowledge and News for the Global Fight Against Cancer.

Copyright © All rights reserved | Newspaperup by Themeansar.

  • Home
  • About Us
    • About Us
    • Advertising Policy
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • DMCA
    • Privacy Policy
    • Terms of Service
  • Contact Us
  • FAQ
  • Sitemap

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.